Etoposide in Malignant Pleural Mesothelioma: Two Phase II Trials of the EORTC Lung Cancer Cooperative Group

By Sahmoud T.   Postmus P.E.   van Pottelsberghe C.   Mattson K.   Tammilehto L.   Splinter T.A.W.   Planting A.S.T.   Sutedja T.   van Pawel J.   van Zandwijk N.   Baas P.   Roozendaal K.J.   Schrijver M.   Kirkpatrick A.   Van Glabbeke M.   Ardizzoni A.   Giaccone G.  

European Journal of Cancer, Vol. 33, Iss. 13, 1997-11 ,pp. : 2211-2215

Elsevier

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in Malignant Pleural Mesothelioma and Non-Small-Cell Lung Cancer

By Dean M. Robinson   Gillian M. Keating   Antona J. Wagstaff  

American Journal of Cancer, Vol. 3, Iss. 6, 2004-01 ,pp. : 387-399

Adis International

Access to resources Recommend Favorite

Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1

By                    

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2411-2419

Spandidos Publications

Access to resources Recommend Favorite

Malignant mesothelioma of the male genital tract - report of two cases

By Sebbag G.   Yan H.   Shmookler B.M.   Sugarbaker P.H.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 6, 2001-11 ,pp. : 261-264

Elsevier

Access to resources Recommend Favorite

Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction

By                    

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1769-1777

Spandidos Publications

Access to resources Recommend Favorite